EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Oxidative Stress in Benign Prostatic Hyperplasia: Mechanisms, Clinical Relevance and Therapeutic Perspectives

Aris Kaltsas iD, Timoleon Giannakas, Marios Stavropoulos, Zisis Kratiras iD, Michael Chrisofos iD

Diseases · 11.02.2025 · 13 (2) · 53

DOI: 10.3390/diseases13020053 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diseases, online erschienen am 11.02.2025. Verfasst von Aris Kaltsas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Third Department of Urology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Benign prostatic hyperplasia (BPH) is among the most common conditions affecting men as they age, resulting in lower urinary tract symptoms (LUTS) that can profoundly impact quality of life. While historically attributed primarily to androgenic imbalances, current evidence implicates additional factors—particularly oxidative stress (OS) and chronic inflammation—in BPH pathogenesis. This review aims to synthesize research on the interplay between OS, inflammation, and hormonal regulation in BPH, emphasizing their clinical relevance and potential therapeutic implications.

Methods

A comprehensive review of peer-reviewed literature was conducted focusing on mechanistic studies, clinical trials, and observational reports. Searches included data on ROS generation, antioxidant capacity, inflammatory mediators, and their contribution to pathological prostatic overgrowth. Potential interventions targeting OS—such as antioxidant supplementation, anti-inflammatory drugs, vitamin D receptor agonists, and phytotherapeutics—were also evaluated for their efficacy and safety profiles.

Results

Chronic inflammation and OS were consistently identified within hyperplastic prostate tissue. Excessive ROS production, diminished antioxidant defense, and sustained cytokine release create a proproliferative and antiapoptotic environment, accelerating disease progression. Metabolic comorbidities (e.g., obesity, insulin resistance) further exacerbate these imbalances. Standard therapies (α-blockers and 5-ARIs) effectively relieve symptoms but do not directly address the oxidative–inflammatory axis. Emerging evidence suggests that pharmacological and dietary approaches targeting OS and inflammation may reduce prostate volume expansion and alleviate LUTS.

Conclusions

Findings indicate that OS and inflammation are key contributors to BPH progression. Incorporating antioxidant and anti-inflammatory strategies alongside conventional treatments holds promise for improving clinical outcomes and patient quality of life. Future research should focus on validating OS-specific biomarkers and optimizing personalized therapy regimens.

Schlagwörter

Stichwörter der Autor:innen

benign prostatic hyperplasiainflammationoxidative stressreactive oxygen species

Autor:innen und Institutionen

  • Third Department of Urology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.

ORCID-Profile: Aris Kaltsas, Zisis Kratiras, Michael Chrisofos

Zitieren

APA

Kaltsas, A., Giannakas, T., Stavropoulos, M., Kratiras, Z., & Chrisofos, M. (2025). Oxidative Stress in Benign Prostatic Hyperplasia: Mechanisms, Clinical Relevance and Therapeutic Perspectives. Diseases, 13(2), 53. https://doi.org/10.3390/diseases13020053

Vancouver

Kaltsas A, Giannakas T, Stavropoulos M, Kratiras Z, Chrisofos M. Oxidative Stress in Benign Prostatic Hyperplasia: Mechanisms, Clinical Relevance and Therapeutic Perspectives. Diseases. 2025;13(2):53. doi:10.3390/diseases13020053

BibTeX
@article{Kaltsas2025,
  author = {Kaltsas, Aris and Giannakas, Timoleon and Stavropoulos, Marios and Kratiras, Zisis and Chrisofos, Michael},
  title = {Oxidative Stress in Benign Prostatic Hyperplasia: Mechanisms, Clinical Relevance and Therapeutic Perspectives},
  journal = {Diseases},
  year = {2025},
  volume = {13},
  number = {2},
  pages = {53},
  doi = {10.3390/diseases13020053}
}
Kostenlos starten →